25 of the Best Oncologists Near Me in fairfax, VA

Alexander Spira is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Spira is highly rated in 88 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Spira is currently accepting new patients.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon-Ching is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.

Leslie Randall is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Randall is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hysterectomy. Dr. Randall is currently accepting new patients.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Subramanian is currently accepting new patients.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner-Iii is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy. Dr. Tanner-Iii is board certified in American Board Of Obstetrics And Gynecology. Dr. Tanner-Iii is currently accepting new patients.

Christina Annunziata is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Annunziata is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Testicular Yolk Sac Tumor. Dr. Annunziata is currently accepting new patients.

George Maxwell is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Falls Church, Virginia. Dr. Maxwell is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Uterine Fibroids, Hysterectomy, and Intrauterine Device Insertion. Dr. Maxwell is currently accepting new patients.

Danielle Shafer is an Oncologist and a Hematologist practicing medicine in Fairfax, Virginia. Dr. Shafer is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy. Dr. Shafer is currently accepting new patients.

Dr. Marion Cole is a specialty care physician board certified in hematology and medical oncology. She joined Inova in 2016 and has been practicing since 2013. Prior to joining Inova, Dr. Marion Cole worked as an oncologist in Fairfax, VA. Dr. Cole has a special interest in hematologic malignancies, multiple myeloma, lymphoma and myelodysplastic syndromes (MDS). She believes that all patients deserve comprehensive care for physical, emotional and spiritual needs when being treated for cancer. Outside of work, Dr. Cole enjoys reading mysteries, hiking, traveling and spending time with family. Dr. Cole is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Breast Cancer, Polycythemia Vera, and Paget Disease of the Breast. Dr. Cole is currently accepting new patients.

Dr. Angel Yu is a specialty oncology care physician board certified in medical oncology, hematology and internal medicine at Inova Health System. She joined Inova in 2020 and has been in medical practice since 2012. Her area of interest is genitourinary cancers, which include prostate, bladder, kidney, and testicular cancers. She completed her undergraduate education at the University of Pennsylvania with a major in biology, after which she received her doctorate in medicine at the Drexel University College of Medicine. She completed her internal medicine and hematology/oncology training at The George Washington University in Washington, D.C. Prior to joining Inova, Dr. Yu worked as a medical oncologist and hematologist with Novant Health and CaroMont Health, both based in North Carolina. She is excited to return to the D.C. area to focus on providing compassionate, personalized and evidence-based oncology care to patients with genitourinary cancers. Dr. Yu is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Prostate Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Yu is currently accepting new patients.

John Elkas is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Elkas is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hernia Surgery. Dr. Elkas is currently accepting new patients.

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine. Dr. Sahebjam is currently accepting new patients.

Gaylord Rose is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Annandale, Virginia. Dr. Rose is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Bladder Reconstruction. Dr. Rose is currently accepting new patients.

Joan Schiller is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Schiller is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.

David Heyer is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Heyer is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), B-Cell Lymphoma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Heyer is currently accepting new patients.

Dr. Rebecca Kaltman is a breast medical oncologist and the inaugural Executive Director of the Inova Saville Cancer Screening and Prevention Center at Inova Schar Cancer. She has played a pivotal role in the conception, launch, and success of this first-of-its-kind center, which centralizes prevention, diagnostics, and education in a single location. Dr. Kaltman earned her undergraduate honors degree from the University of Michigan and her medical degree from MCP-Hahnemann University School of Medicine. She completed her training in internal medicine and medical oncology at the University of Pennsylvania. Following her training, she joined the faculty at the University of Pennsylvania School of Medicine as a breast oncologist and clinical researcher at the Rena Rowan Breast Center, part of the Abramson Cancer Center. Throughout her career, Dr. Kaltman has focused on caring for patients with breast cancer and those with hereditary cancer syndromes. At Inova, she has expanded cancer prevention and early detection services across Northern Virginia and beyond. She launched a mobile cancer screening bus to bring care to at-risk communities and developed clinical research studies aimed at identifying optimal cancer screening strategies for firefighters. Additionally, she has served as a principal investigator for next-generation cancer screening clinical trials and helped design a comprehensive colon cancer screening strategy that significantly increased screening rates across the health system. In recognition of her exemplary leadership and dedication, Dr. Kaltman was appointed to the Health Policy Committee of the American Society of Clinical Oncology for a three-year term and serves on the board of the Cancer Action Coalition of Virginia. Blog Posts and Podcasts Virginia Hospital & Healthcare Association's Patients Come First Podcast (July 30, 2023) Understanding Risk: The First Step in Breast Cancer Prevention (December 2022). Dr. Kaltman is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Kaltman is currently accepting new patients.

Dr. Saveri Bhattacharya is a specialty care physician, board certified in internal medicine and medical oncology. She joined Inova in 2025 and has been practicing since 2011. Prior to joining Inova, Dr. Bhattacharya served as an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Bhattacharya specializes in uterine, ovarian, cervical and vulvar cancers. She is active in clinical research and has served as both a primary investigator and co-investigator on numerous clinical trials. In 2019, she received the GOG New Investigator Award. She is a member of NRG Oncology, the GOG Foundation and the American Society of Clinical Oncology. In her spare time, Dr. Bhattacharya enjoys traveling, running, reading and playing tennis. Dr. Bhattacharya is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Deeken joined Inova in 2013 and has more than 21 years of clinical experience in internal medicine and medical oncology. He serves as the President of Inova Schar Cancer Institute and Medical Director for the Inova Schar Head and Neck Cancer Program. His clinical research focuses on the use of immunotherapy treatments while his laboratory research takes a closer look at understanding the growing epidemic of head and neck cancers caused by HPV. This includes understanding the tumor mutations that are induced by HPV infection and how those tumors can be better treated with targeted therapies. He believes that gaining a better understanding of genomic factors may explain who might be at risk for developing HPV-caused head and neck cancer. Dr. Deeken served on the national Head and Neck Cancer Scientific Committee for the American Society of Clinical Oncology (ASCO) and currently serves on ASCO's Government Relations Committee. Prior to joining Inova, he was Director of the Head and Neck Medical Oncology Program at the Lombardi Comprehensive Cancer Center at Georgetown University and Regional Director for Medical Oncology for MedStar Health. He currently serves as Professor of Medicine at the University of Virginia. Dr. Deeken received his Doctor of Medicine from Georgetown University, where he also did his residency in internal Medicine. He did his fellowship training in medical oncology at the National Cancer Institute. A native of Wisconsin, Dr. Deeken is married and has 4 children. Dr. Deeken is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Oral Squamous Cell Carcinoma. Dr. Deeken is currently accepting new patients.

Dr. Jennifer Matro is a specialty care physician board certified in medical oncology who specializes in the treatment of all types of breast cancer. She joined Inova in 2025 and has been practicing since 2008. Before joining Inova, she served on the faculty as a breast oncologist and Assistant Professor of Clinical Medicine at the University of Pennsylvania. Most recently, she served as an Associate Clinical Professor of Medicine and Clinical Service Chief in the Division of Hematology/Oncology at the University of California San Diego. Dr. Matro offers compassionate, multidisciplinary care to provide her patients with the most appropriate and advanced treatment. Throughout her career, she has focused on treating all types of invasive breast cancer, with expertise and interest in metastatic breast cancer and the unique needs of young women, pregnant women, and athletes diagnosed with breast cancer. In addition to her clinical work, Dr. Matro has taught medical students, residents and fellows. She also lectures regionally and nationally to educate community oncologists and other practitioners about the most recent advances in breast cancer care. She is actively involved in research and clinical trials aimed at reducing the risk of breast cancer recurrence and optimizing the treatment of advanced breast cancer. Dr. Matro completed a hematology/oncology fellowship at Fox Chase Cancer Center at Temple University Hospital, where she was named chief fellow during her third year and twice earned an American Society of Clinical Oncology (ASCO) merit award. Dr. Matro completed her residency and earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She is a member of the American Society of Clinical Oncology. In her free time, Dr. Matro enjoys spending time with her daughter and goldendoodle. She also likes running, hiking, cycling, traveling and trying new restaurants. Dr. Matro is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Matro is currently accepting new patients.

Gregory Orloff is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Orloff is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Paget Disease of the Breast, and Familial Pancreatic Cancer. Dr. Orloff is currently accepting new patients.

Dr. Angela Pennisi is a specialty care physician board certified in internal medicine, medical oncology and hematology. She has a special interest in the management of all types and stages of breast cancer. Dr. Pennisi is passionate about connecting with her patients for personalized care and providing comprehensive oncology care from diagnosis to survivorship, while advancing breast cancer research. She received her medical degree from the University of Catania School of Medicine and Surgery in Catania, Italy. She continued her fellowship training in hematology and received a PhD in experimental hematology from the same university. After completing her hematology/oncology fellowship at the University of Arkansas for Medical Sciences, Dr. Pennisi served at the same institution as assistant professor of medicine with a clinical focus in breast cancer. She has been an investigator in several translational studies and clinical trials to improve therapeutic approaches in the treatment of patients with breast cancer. She joined Inova Medical Group with more than 10 years of clinical experience. A native of Italy, Dr. Pennisi currently resides in Northern Virginia with her husband and two children. In her spare time she likes to spend time with her family, exercise and travel. Memberships/Accreditations American Society of Clinical Oncology American Society of Hematology. Dr. Pennisi is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Vulvectomy. Dr. Pennisi is currently accepting new patients.

D’Aniello Director, Breast Cancer Research Medical Director, Breast Medical Oncology Inova Schar Cancer Dr. Kathleen Harnden is a specialty care physician board certified in medical oncology and internal medicine at Inova Health System. She has a special interest in the management of breast cancer, particularly in premenopausal women. Dr. Harnden joined Inova Schar Cancer Institute after the completion of her hematology/oncology fellowship at Duke University Medical Center in Durham, NC. She is an MBA graduate from the University of Virginia Darden School of Business. Dr. Harnden has numerous publications in national journals and has presented at national meetings on topics in breast cancer. Her research has focused on early phase clinical trials in breast cancer, breast cancer genomics and individualized treatment for patients based on advanced testing results. She is and has been a principal investigator on several phase I clinical trials in metastatic breast cancer and is interested in developing novel therapies for breast cancer. A native of Vienna, VA, Dr. Harnden currently resides in Oakton, VA with her husband, a gastroenterology physician, and their three children. In her spare time, she enjoys spending time with her family, jogging, vacationing on Cape Cod and traveling the world. Dr. Harnden is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Harnden is currently accepting new patients.

Dr. Joshua Allen is a specialty care physician board certified in hematology, medical oncology and internal medicine. He joined Inova in 2020 and has been practicing since 2017. A native of Utah, Dr. Allen resides in Northern Virginia with his wife and children. Outside of work, he enjoys music (piano and violin), the outdoors and traveling. Dr. Allen is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Thrombocytopenia, and Wilms Tumor. Dr. Allen is currently accepting new patients.

Abby Meyers is an Oncologist and a Pediatric Endocrinologist practicing medicine in Fairfax, Virginia. Dr. Meyers is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Congenital Adrenal Hyperplasia (CAH), and Neurohypophyseal Diabetes Insipidus. Dr. Meyers is board certified in Pediatrics: American Board Of Pediatrics, 2016 and Pediatric Endocrinology: American Board Of Pediatrics, 2021. Dr. Meyers is currently accepting new patients.